Durani Cosmetics GmbH
- Address
- lock Available on a paid plan
Durani Cosmetics GmbH - Dermatological Research Center
Durani Cosmetics GmbH is a specialized research facility focused on dermatological conditions and topical therapeutic interventions. The center demonstrates expertise in conducting clinical efficacy studies for parasitic skin infections and developing innovative treatment protocols for challenging dermatological disorders.
- Scabies treatment optimization and therapeutic protocols
- Topical permethrin-based interventions for parasitic skin conditions
- Comparative efficacy studies of dermatological cream formulations
The facility's research methodology emphasizes staged clinical evaluation with systematic assessment of treatment success rates following standard and repeated application protocols. Their work on InfectoScab 5% cream and permethrin 10% formulations reflects a commitment to evidence-based dermatological therapeutics, with particular attention to dose-response relationships and whole-body application strategies for optimal patient outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Durani Cosmetics GmbH
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase III/IV Multicenter Trial on Escalating Treatment of Scabies with Permethrin 5% and 10% Cream and Ivermectin Tablets | INFECTOPHARM Arzneimittel und Consilium GmbH | Phase III | Recruiting | Oct 2024 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ivermectin | 1 | Unknown | 2024-10-01 | 2024-10-01 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.